Impaired lymphocyte reconstitution after autologous transplant is associated with apoptosis of CD8+ T cells and adverse clinical outcome

References

• Powles R, Singhal S, Treleaven J, et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood. 1998;91:3481–3486.
   PubMed Web of Science ®Google Scholar
• Kim H, Sohn HJ, Kim S, et al. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant. 2006;37:1037–1042.
   PubMed Web of Science ®Google Scholar
• Savani BN, Mielke S, Rezvani K, et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13:1216–1223.
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Barrett AJ, Schaffer M, et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant. 2009;15:1108–1115.
   PubMed Web of Science ®Google Scholar
• Rueff J, Medinger M, Heim D, et al. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma. Biol Blood Marrow Transplant. 2014;20:896–899.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Inwards DJ, Ansell SM, et al. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant. 2008;14:807–816.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Inwards DJ, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood. 2001;98:579–585.
   PubMed Web of Science ®Google Scholar
• Nordoy T, Kolstad A, Endresen P, et al. Persistent changes in the immune system 4–10 years after ABMT. Bone Marrow Transplant. 1999;24:873–878.
   PubMed Web of Science ®Google Scholar
• Zheng H, Matte-Martone C, Jain D, et al. Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia. J Immunol. 2009;182:5938–5948.
   PubMed Web of Science ®Google Scholar
• Tartakovsky B, Fried M, Bleiberg M, et al. An intracellular antigen that reacts with MO2, a monoclonal antibody to CD14, is expressed by human lymphocytes. Immunol Lett. 2003;85:35–40.
   PubMed Web of Science ®Google Scholar
• Waring P, Beaver J. Gliotoxin and related epipolythiodioxopiperazines. Gen Pharmacol. 1996;27:1311–1316.
   PubMedGoogle Scholar
• Tartakovsky B, Zigman-Hofman E, Senyor G, et al. A peptide of CD14 protects human lymphocytes from gliotoxin-induced apoptosis. Int J Pept Res Ther. 2012;18:249–258.
   Web of Science ®Google Scholar
• Ashihara E, Shimazaki C, Yamagata N, et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant. 1994;13:377–381.
   PubMed Web of Science ®Google Scholar
• Henon PR, Liang H, Beck-Wirth G, et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 1992;9:285–291.
   PubMed Web of Science ®Google Scholar
• Hoepfner S, Haut PR, O'Gorman M, et al. Rapid immune reconstitution following autologous hematopoietic stem cell transplantation in children: a single institution experience. Bone Marrow Transplant. 2003;31:285–290.
   PubMed Web of Science ®Google Scholar
• Koehne G, Zeller W, Stockschlaeder M, et al. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1997;19:149–156.
   PubMed Web of Science ®Google Scholar
• Rutella S, Rumi C, Laurenti L, et al. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol. 2000;108:105–115.
   PubMed Web of Science ®Google Scholar
• Shenoy S, Mohanakumar T, Todd G, et al. Immune reconstitution following allogeneic peripheral blood stem cell transplants. Bone Marrow Transplant. 1999;23:335–346.
   PubMed Web of Science ®Google Scholar
• Maile R, Barnes CM, Nielsen AI, et al. Lymphopenia-induced homeostatic proliferation of CD8+ T cells is a mechanism for effective allogeneic skin graft rejection following burn injury. J Immunol. 2006;176:6717–6726.
   PubMed Web of Science ®Google Scholar
• Amadori A, Zamarchi R, De Silvestro G, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med. 1995;1:1279–1283.
   PubMed Web of Science ®Google Scholar
• Hiwase DK, Hiwase S, Bailey M, et al. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2008;14:116–124.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Geyer SM, et al. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia. 2004;18:1085–1092.
   PubMed Web of Science ®Google Scholar
• Hebib NC, Deas O, Rouleau M, et al. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles. Blood. 1999;94:1803–1813.
   PubMed Web of Science ®Google Scholar
• Wang XS, Shi Q, Williams LA, et al. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma. 2015;56:1335–1341.
   PubMed Web of Science ®Google Scholar